Skip to main content
Erschienen in: NeuroMolecular Medicine 2-3/2017

09.08.2017 | Original Paper

Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis

verfasst von: Shiek S. S. J. Ahmed, R. S. Akram Husain, Suresh Kumar, V. Ramakrishnan

Erschienen in: NeuroMolecular Medicine | Ausgabe 2-3/2017

Einloggen, um Zugang zu erhalten

Abstract

Schizophrenia is a complex psychiatric disorder characterized by memory impairments with delusions and hallucinations. Several investigations have focused on determining the association between NOS1 (nitric oxide synthase-1) polymorphisms and risk of schizophrenia (SZ). However, the association of rs2682826, rs3782206, rs499776, rs3782219, rs41279104, rs3782221, rs1879417, rs4767540, rs561712, and rs6490121 polymorphisms with schizophrenia remains inconclusive. We performed a systematic meta-analysis for each polymorphism to determine its association with SZ by calculating their pooled odds ratio and 95% confidence intervals. The heterogeneity between studies was evaluated using Cochran’s Q test to adopt random effects or fixed effects model. Based on our analysis, the rs3782206 polymorphism showed a strongest association with schizophrenia in allelic OR 1.15 (95% CI [1.05–1.25]), homozygote OR 1.35 (95% CI [1.09–1.66]), dominant OR 1.16 (95% CI [1.04–1.29]), and recessive OR 1.29 (95% CI [1.05–1.58]) models in Asian population. Similarly, in Caucasian population, the rs499776 polymorphism attributes risk association in homozygote OR 0.70 (95% CI [0.50–0.98]), dominant OR 3.57 (95% CI [2.34–5.27]), and recessive models OR 0.68 (95% CI [0.50–0.93]) with schizophrenia. Further, the sensitivity analysis was carried out based on leave-one-out method to confirm the reliability of the analysis. Overall, our meta-analysis demonstrates the significance of NOS1 genetic variants that are functionally associated with cognitive and neuropsychiatric symptoms of schizophrenia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ahmed, S. S., Husain, R. A., Kumar, S., & Ramakrishnan, V. (2016). Association between MDR1 gene polymorphisms and Parkinson’s disease in Asian and Caucasian populations: A meta-analysis. Journal of the Neurological Sciences, 368, 255–262.CrossRefPubMed Ahmed, S. S., Husain, R. A., Kumar, S., & Ramakrishnan, V. (2016). Association between MDR1 gene polymorphisms and Parkinson’s disease in Asian and Caucasian populations: A meta-analysis. Journal of the Neurological Sciences, 368, 255–262.CrossRefPubMed
Zurück zum Zitat Alirezamousa, M., Ahmad, E., & Tahereh, N. (2013). Evaluation of NOS3 gene G894T polymorphism in Iranian patients affected by schizophrenia and normal individuals. International Journal of Basic-Biosciences, 1, 20–25. Alirezamousa, M., Ahmad, E., & Tahereh, N. (2013). Evaluation of NOS3 gene G894T polymorphism in Iranian patients affected by schizophrenia and normal individuals. International Journal of Basic-Biosciences, 1, 20–25.
Zurück zum Zitat Armitage, P., Berry, G., & Matthews, J. N. S. (2008). Statistical methods in medical research. New York: Wiley. Armitage, P., Berry, G., & Matthews, J. N. S. (2008). Statistical methods in medical research. New York: Wiley.
Zurück zum Zitat Bernstein, H. G., Bogerts, B., & Keilhoff, G. (2005). The many faces of nitric oxide in schizophrenia. A review. Schizophrenia Research, 78(1), 69–86.CrossRefPubMed Bernstein, H. G., Bogerts, B., & Keilhoff, G. (2005). The many faces of nitric oxide in schizophrenia. A review. Schizophrenia Research, 78(1), 69–86.CrossRefPubMed
Zurück zum Zitat Braver, T. S., Barch, D. M., & Cohen, J. D. (1999). Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function. Biological Psychiatry, 46(3), 312–328.CrossRefPubMed Braver, T. S., Barch, D. M., & Cohen, J. D. (1999). Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function. Biological Psychiatry, 46(3), 312–328.CrossRefPubMed
Zurück zum Zitat Brinza, S., Dumitru, K., & Zelikovsky, A. (2006). Case (control)-free multi-SNP combinations in case-control studies. Algorithmic Biology, 1–2. Brinza, S., Dumitru, K., & Zelikovsky, A. (2006). Case (control)-free multi-SNP combinations in case-control studies. Algorithmic Biology, 1–2.
Zurück zum Zitat Cui, H., Nishiguchi, N., Yanagi, M., Fukutake, M., Mouri, K., Kitamura, N., et al. (2010). A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophernia Research, 121, 172–178.CrossRef Cui, H., Nishiguchi, N., Yanagi, M., Fukutake, M., Mouri, K., Kitamura, N., et al. (2010). A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophernia Research, 121, 172–178.CrossRef
Zurück zum Zitat Donohoe, G., Walters, J., Morris, D. W., et al. (2009). Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Archives of General Psychiatry, 66, 1045–1054.CrossRefPubMed Donohoe, G., Walters, J., Morris, D. W., et al. (2009). Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Archives of General Psychiatry, 66, 1045–1054.CrossRefPubMed
Zurück zum Zitat Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., et al. (2007). Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell, 130, 1146–1158.CrossRefPubMedPubMedCentral Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., et al. (2007). Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell, 130, 1146–1158.CrossRefPubMedPubMedCentral
Zurück zum Zitat Fallin, M. D., Lasseter, V. K., Avramopoulos, D. R., Nicodemus, K. K., Wolyniec, P. S., McGrath, J. A., et al. (2005). Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. The American Journal of Human Genetics, 77, 918–936.CrossRefPubMed Fallin, M. D., Lasseter, V. K., Avramopoulos, D. R., Nicodemus, K. K., Wolyniec, P. S., McGrath, J. A., et al. (2005). Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. The American Journal of Human Genetics, 77, 918–936.CrossRefPubMed
Zurück zum Zitat Gejman, P., Sanders, A., & Duan, J. (2010). The role of genetics in the etiology of Schizophrenia. The Psychiatric Clinics of North America, 33, 35–66.CrossRefPubMedPubMedCentral Gejman, P., Sanders, A., & Duan, J. (2010). The role of genetics in the etiology of Schizophrenia. The Psychiatric Clinics of North America, 33, 35–66.CrossRefPubMedPubMedCentral
Zurück zum Zitat Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006). Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research, 81(1), 47–63.CrossRefPubMed Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006). Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research, 81(1), 47–63.CrossRefPubMed
Zurück zum Zitat Huedo Medina, T. B., Sanchez-Meca, J., Marin Martinez, F., Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11, 193–206. International Journal of Basic Biosciences, 1, 20–25. Huedo Medina, T. B., Sanchez-Meca, J., Marin Martinez, F., Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11, 193–206. International Journal of Basic Biosciences, 1, 20–25.
Zurück zum Zitat Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. The Lancet, 373, 31–41.CrossRef Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. The Lancet, 373, 31–41.CrossRef
Zurück zum Zitat Li, H., Wetten, S., Li, L., Jean, P. L., Upmanyu, R., Surh, L., et al. (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology, 65, 45–53.CrossRefPubMed Li, H., Wetten, S., Li, L., Jean, P. L., Upmanyu, R., Surh, L., et al. (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology, 65, 45–53.CrossRefPubMed
Zurück zum Zitat Liu, B. (2006). Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease. The AAPS Journal, 8, 606–621.CrossRef Liu, B. (2006). Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease. The AAPS Journal, 8, 606–621.CrossRef
Zurück zum Zitat Nasyrova, R. F., Ivashchenko, D. V., Ivanov, M. V., & Neznanov, N. G. (2015). Role of nitric oxide and related molecules in schizophrenia pathogenesis: Biochemical, genetic and clinical aspects. Frontiers in Physiology, 6, 1–16. Nasyrova, R. F., Ivashchenko, D. V., Ivanov, M. V., & Neznanov, N. G. (2015). Role of nitric oxide and related molecules in schizophrenia pathogenesis: Biochemical, genetic and clinical aspects. Frontiers in Physiology, 6, 1–16.
Zurück zum Zitat O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40, 1053–1055.CrossRefPubMed O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40, 1053–1055.CrossRefPubMed
Zurück zum Zitat Okumura, T., Okochi, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., et al. (2009). No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Neuromolecular Medicine, 11, 123–127.CrossRefPubMed Okumura, T., Okochi, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., et al. (2009). No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Neuromolecular Medicine, 11, 123–127.CrossRefPubMed
Zurück zum Zitat Paul Flicek, M., Ridwan A., Daniel B., Kathryn B., Konstantinos B., Simon B., et al. (2014). Ensemble 2014. Nucleic Acids Research: 42 Database issue: D749–D755. Paul Flicek, M., Ridwan A., Daniel B., Kathryn B., Konstantinos B., Simon B., et al. (2014). Ensemble 2014. Nucleic Acids Research: 42 Database issue: D749–D755.
Zurück zum Zitat Ramakrishnan, V., Alphonsa, T. A., Husain, R. A., Ahmed, S. S., Subramaniyan, K., & Kumar, S. (2016). Association of rs1801582 and rs1801334 PARK2 Polymorphisms with risk of Parkinson’s disease: A case-control study in South India and Meta-Analysis. Meta Gene, 10, 32–38.CrossRef Ramakrishnan, V., Alphonsa, T. A., Husain, R. A., Ahmed, S. S., Subramaniyan, K., & Kumar, S. (2016). Association of rs1801582 and rs1801334 PARK2 Polymorphisms with risk of Parkinson’s disease: A case-control study in South India and Meta-Analysis. Meta Gene, 10, 32–38.CrossRef
Zurück zum Zitat Ramakrishnan, V., Husain, R. A., & Ahmed, S. S. (2017). Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis. Journal of Neuroimmunology, 306, 11–18.CrossRefPubMed Ramakrishnan, V., Husain, R. A., & Ahmed, S. S. (2017). Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis. Journal of Neuroimmunology, 306, 11–18.CrossRefPubMed
Zurück zum Zitat Reif, A., Herterich, S., Strobel, A., Ehlis, A. C., Saur, D., Jacob, C. P., et al. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular Psychiatry, 11, 286–300.CrossRefPubMed Reif, A., Herterich, S., Strobel, A., Ehlis, A. C., Saur, D., Jacob, C. P., et al. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular Psychiatry, 11, 286–300.CrossRefPubMed
Zurück zum Zitat Riley, B., Thiselton, D., Maher, B. S., Bigdeli, T., Wormley, B., McMichael, G. O., et al. (2010). Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Molecular Psychiatry, 15, 29–37.CrossRefPubMed Riley, B., Thiselton, D., Maher, B. S., Bigdeli, T., Wormley, B., McMichael, G. O., et al. (2010). Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Molecular Psychiatry, 15, 29–37.CrossRefPubMed
Zurück zum Zitat Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M., & Coyle, J. T. (2006). Neurobiology of schizophrenia. Neuron, 52, 139–153.CrossRefPubMed Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M., & Coyle, J. T. (2006). Neurobiology of schizophrenia. Neuron, 52, 139–153.CrossRefPubMed
Zurück zum Zitat Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009). Epigenetic mechanisms in schizophrenia. Biochimicaet Biophysica Acta, 9, 869–877.CrossRef Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009). Epigenetic mechanisms in schizophrenia. Biochimicaet Biophysica Acta, 9, 869–877.CrossRef
Zurück zum Zitat Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Molecular Psychiatry, 7, 560–563.CrossRefPubMed Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Molecular Psychiatry, 7, 560–563.CrossRefPubMed
Zurück zum Zitat Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non-randomized studies in meta-analyses. European Journal of Epidemiology, 25, 603–605.CrossRefPubMed Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non-randomized studies in meta-analyses. European Journal of Epidemiology, 25, 603–605.CrossRefPubMed
Zurück zum Zitat Stefanovic, B., Schwindt, W., Hoehn, M., & Silva, A. C. (2007). Functional uncoupling of hemodynamic from neuronal response by inhibition of neuronal nitric oxide synthase. Journal of Cerebral Blood Flow and Metabolism, 27(4), 741–754.CrossRefPubMed Stefanovic, B., Schwindt, W., Hoehn, M., & Silva, A. C. (2007). Functional uncoupling of hemodynamic from neuronal response by inhibition of neuronal nitric oxide synthase. Journal of Cerebral Blood Flow and Metabolism, 27(4), 741–754.CrossRefPubMed
Zurück zum Zitat Tang, W., Huang, K., Tang, R., Zhou, G., Fang, C., Zhang, J., et al. (2008). Evidence for association between the 5′ flank of the NOS1 gene and schizophrenia in the Chinese population. International Journal of Neuropsychopharmacology, 11, 1063–1071.CrossRefPubMed Tang, W., Huang, K., Tang, R., Zhou, G., Fang, C., Zhang, J., et al. (2008). Evidence for association between the 5′ flank of the NOS1 gene and schizophrenia in the Chinese population. International Journal of Neuropsychopharmacology, 11, 1063–1071.CrossRefPubMed
Zurück zum Zitat Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320, 539–543.CrossRefPubMed Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320, 539–543.CrossRefPubMed
Zurück zum Zitat Ward, M. E., Toporsian, M., Scott, J. A., Teoh, H., Govindaraju, V., Quan, A., et al. (2005). Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. The Journal of Clinical Investigation, 115(11), 3128–3139.CrossRefPubMedPubMedCentral Ward, M. E., Toporsian, M., Scott, J. A., Teoh, H., Govindaraju, V., Quan, A., et al. (2005). Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. The Journal of Clinical Investigation, 115(11), 3128–3139.CrossRefPubMedPubMedCentral
Zurück zum Zitat Weber, H., Klamer, D., Freudenberg, F., Kittel-Schneider, S., Rivero, O., Scholz, C. J., et al. (2013). The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. European Neuropsychopharmacology, 24, 65–85.CrossRefPubMed Weber, H., Klamer, D., Freudenberg, F., Kittel-Schneider, S., Rivero, O., Scholz, C. J., et al. (2013). The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. European Neuropsychopharmacology, 24, 65–85.CrossRefPubMed
Zurück zum Zitat Zhang, Z., Chen, X., Yu, P., Zhang, Q., Sun, X., Gu, H., et al. (2014). Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls. Neuropsychopharmacology, 40, 1383–1394.CrossRefPubMed Zhang, Z., Chen, X., Yu, P., Zhang, Q., Sun, X., Gu, H., et al. (2014). Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls. Neuropsychopharmacology, 40, 1383–1394.CrossRefPubMed
Zurück zum Zitat Ziegler, A., Van Steen, K., & Wellek, S. (2011). Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis. Breast Cancer Research and Treatment, 128, 197–201.CrossRefPubMed Ziegler, A., Van Steen, K., & Wellek, S. (2011). Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis. Breast Cancer Research and Treatment, 128, 197–201.CrossRefPubMed
Metadaten
Titel
Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis
verfasst von
Shiek S. S. J. Ahmed
R. S. Akram Husain
Suresh Kumar
V. Ramakrishnan
Publikationsdatum
09.08.2017
Verlag
Springer US
Erschienen in
NeuroMolecular Medicine / Ausgabe 2-3/2017
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-017-8460-z

Weitere Artikel der Ausgabe 2-3/2017

NeuroMolecular Medicine 2-3/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.